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1. Introduction 2. Materials and methods 
A Ca’+-stimulated and Mg**-dependent ATPase 
(Ca*+ t Mg*+-ATPase) activity exists in plasma mem- 
brane preparations from a variety of cells [l-7] 
including pancreatic islets [8]. In the erythrocyte 
plasma membrane, the Ca** t Mg*+-ATPase is generally 
recognized as the enzymatic basis for active or ATP- 
dependent calcium extrusion. In this membrane, cal- 
mod&n has been shown to stimulate both ATPde- 
pendent Ca*+ transport [9] and Ca*+ t Mg2+-ATPase 
activity [ 1,101. However, apart from the erythrocyte 
and synaptic plasma membranes of brain [4], it has 
not been possible to demonstrate a calmodulin-depen- 
dent regulation of plasma membrane Ca*+ + Mg*+- 
ATPase activity in other tissues. 
Male Wistar strain rats (150-l 75 g) were obtained 
from Charles Rivers Labs (Wilmington MA). [T-~‘P]- 
ATP was purchased from ICN Corp. and Omnifluor 
from New England Nuclear (Boston MA). The pheno- 
thiazines, trifluoperazine and fluphenazine were gifts 
from Dr Harry Green (Smith, Kline and French) and 
chlorpromazine was obtained from Sigma Chemical 
Co. (St Louis MO). Cahnodulin was prepared from 
rat brain utilizing fluphenazine agarose chromatog 
raphy [15,16]. 
High levels of calmodulin have been demonstrated 
in islet cells [ 11,141. Calmodulin has been indirectly 
implicated in stimulus-secretion coupling by pheno- 
thiazine-induced inhibition of insulin release from 
perifused islets [ 121, and directly by calciumdepen- 
dent activation of CAMP phosphodiesterase [ 131, 
adenylate cyclase [111, protein kinase [ 141, and ATP- 
dependent calcium transport in plasma membrane 
vesicles [8]. Here’, we report that like ATP-dependent 
Ca*+ transport [8], the Ca2+ t Mg*+-ATPase of the 
islet-cell plasmamembrane is regulated by calmodulin. 
Furthermore, Mg*+ appears to be required for activa- 
tion of the ATPase by cahnodulin. 
Abbreviations: CPZ, chlorpromazine; TFP, trifluoperazine; 
FLU, fluphenazine; SDS, sodium dodecyl sulfate; MES, 
2(N-morpholino) ethane sulfonic acid; Pipes, piperazine-N,M- 
bis (2ethane sulfonic acid) 
Pancreatic islets were isolated by collagenase diges- 
tion [ 171 and separated on dialyzed Ficoll gradients 
[ 181. Plasma membranes were prepared and charac- 
terized as in [ 191 with the following modifications. 
islets were homogenized in an isotonic buffer (50 mM 
MES, 1 mM EDTA, and 250 mM sucrose, pH 7.2) and 
nuclei and cell debris were removed by centrifugation 
at 600 X g for 5 min. A membrane particulate pellet 
obtained by centrifugation i  the same buffer at 
20 000 X g for 20 min, was rehomogenized in hypo- 
tonic medium (10 mM MES, 1 mM EGTA, pH 6), 
layered on a discontinuous sucrose gradient and cen- 
trifuged at 150 000 X g for 90 min. The plasma mem- 
brane-enriched fraction was collected from 1.14 and 
1 .16 density gradient layers. These fractions were 
characterized by 1 O-fold enrichment of 5’-nucleotidase 
specific activity and 1 l-fold enrichment of the bind- 
ing of ‘*‘I-labeled WGA compared to the homogenate. 
The plasma membrane fractions were resuspended 
and sonicated (Branson Sonifier 200) at 4°C for three 
5 s intervals at 18 W, pelleted at 150 000 X g for 
60 min, resuspended in hypotonic media and frozen 
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at -40°C. Protein content was determined by a flu- 
orometric method [20] with modifications as in [21]. 
The Ca2+ t Mg2+-ATPase activity was assayed by 
monitoring the release of 32P from [T-~“P] ATP in 
0.5-l .O ml reaction vol. The assay medium contained 
2 fig protein, 10 mM Tris-Pipes (PH 7.5), 20 mM 
NaN3, 2 mM EGTAand 0.25 mM [-r-32P] ATP (1 .O /.&i/ 
tube). The assays were run at pH 7.2 for 30 min at 
37’C and the reaction was terminated by the addi- 
tion of 500 /.d 3% SDS. Calcium when present was 1.6 
or 1.9 mM (equivalent to 0.2 and 1 .l FM free calcium, 
respectively). The calcium stocks were standardized 
by atomic absorption spectroscopy and the free cal- 
cium levels were determined as in [8] with stability 
constant for Ca’+-EGTA at pH 7.2 being 107*24. Cal- 
cium-stimulated ATPase activity was determined by 
subtracting values obtained with 2 mM EGTA alone 
(Mg’+-ATPase) from those obtained in the presence 
of chelator and calcium. Although there is a require- 
ment for PM levels of Mg2+ for the expression of 
Ca2+-stimulated ATPase activity [8] a further increase 
in Mg2+ increases the Mg2+-ATPase activity and 
produces an apparent reduction in the calcium-stim- 
ulated activity. Thus, most studies employed endog- 
enous levels of Mg2+ (8.5-9 PM). To establish the 
Mg2+ requirement for cahnoduhn, ATPase assays were 
also performed in the presence of 200 PM Mg2+ t 
1.5 mM ATP. Calmodulin was 2.8-24 pg/ml [ 168- 
1440 nM] at 1 .l (uM free Ca’+. 
A modification of the procedures in [22] was used 
to aid in removing avidly bound endogenous cahno- 
dulin from islet cell plasma membranes. Frozen and 
thawed membranes were incubated for 30 min at 4°C 
in the presence of 10 mM Tris-Pipes (pH 7.5), 2 mM 
EGTA, 1.9 mM CaC12 and 100 PM TFP. This prepara- 
tion was then centrifuged at 150 000 X g for 60 min, 
resuspended in 10 mM MES + 1 mM EGTA and used 
in the Ca2+  Mg2+-ATPase assay. 
3. Results 
The specific activity of the Mg2+-ATPase d ter- 
mined in the presence of endogenous Mg2+ was 
10.6 & 1.6 nm Pi . mg protein-‘. min-’ and the Ca’+- 
stimulated activity was 106 f 15 mn Pi . mg-’ . min-’ 
in the presence of 0.2 @v! free Ca2+ (IV= 4). The effect 
of 3 different phenothiazines was evaluated on the 
Ca2+  Mg2*-ATPase obtained from islet cell plasma 
membranes. As indicated in tig.1, half-maximal inhibi- 
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Fig.1. Phenothiazine-induced inhibition of Cal+ + Mg’+- 
ATPase. Three separate islet-cell plasma membrane fractions 
were evaluated without added Mg”+ for Ca2+ + Mg*+-ATPase 
activity. Incubations (30 min, 37°C) contained chlorpromazine 
(CPZ, l ), fluphenazine (FLU, o), or trifluoperazine (TFP, A) 
with 0.2 NM free Ca’+. The data represent he mean * SEM 
percent of Cal+-stimulated ATPase in the absence of pheno- 
thiazine (146 f 34 nm Pi . mg protein-’ . min-‘). Assuming 
maximal inhibition at 300 MM phenothiazine, half-maximal 
inhibition occurred at 163 FM CPZ, 119 GM FLU and 75 MM 
TFP. 
tion of the Ca2+-stimulated activity occurred at 75 FM 
TFP, with maximal inhibition (86%) being observed 
in the presence of 200 PM TFP. The addition of FLU 
to the incubation medium also produced a dose- 
dependent inhibition of the Ca’+-stimulated activity 
with a similar degree of potency, whereas CPZ was 
the least effective of the phenothiazines in inhibiting 
the Ca2* t Mg2+-ATPase activity. Neither TFP, FLU 
nor CPZ affected the Mg2+-ATPase activity over the 
range of concentrations evaluated in the absence of 
exogenous Mg2*. 
Phenothiazines also inhibited the Ca2+ t Mg’+: 
ATPase in a dose-dependent manner when assayed in 
the presence of 200 PM Mg’*. Ah 3 phenothiazines 
tested produced agreater % inhibition of Ca2+ t Mg2*- 
ATPase in the presence of 200 PM Mg2+ as compared 
to the inhibition obtained in the absence of added 
Mg2* (table 1). It was also observed that in the 
presence of 200 nM Mg’+, the phenothiazines inhibited 
the Mg2+-ATPase activity at 2100 PM (not shown). 
Even though the inhibition of the Ca2+ t Mg2+- 
ATPase activity by phenothiazines suggested that the 
membranes contain endogenously bound cahnodulin, 
the Ca2+ t Mg2+-stimulated ATPase could be stimulated 
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Table 1 Table 2 
Effect of Mg’+ on phenothiazine-induced inhibition of 
Cal+ + Mgs+-ATPase activity 
Effect of calmodulin on Ca*+ + Mg”+-ATPase activity in 
control and TFP pretreated plasma membranes without 
added Mga+ 
Agent Ca”+ + Mg’+-ATPase (% control) 




91.7 * 3.5 76.0 * 8.9 
72.8 f 3.9 31.7 f 9.2 
70.9 * 4.4 55.0 f 10.5 
Incubations were performed (30 min, 37°C) with or without 
added Mg”+ and at 50 PM phenothiazine. The data represent 
the percent of Cas+-stimulated ATPase activity determined in 
the absence of phenothiazine (mean f SEM, N = 3-4). Con- 
trol Caz+ + Mgl+-ATPase was 140 f 33 and 5 2 f 8 nm Pi. mg-’ . 
min-’ at endogenous and 200 PM Mg’+, respectively 
further by the addition of calmodulin (fig.2, lower 
curve). In this assay system, 200 ErM Mg2+ was included 
in the incubation medium and the degree of enhance- 
ment of this enzyme activity depended both on 
[Ca2’] as well as [calmodulin]. Preliminary studies 
determined free Ca2* at 1 .l PM as optimal for obtain- 
ing calmodulin stimulation of Ca2+ t Mg’+-ATPase 











s I 1 I I J 0 3 6 9 12 15 
18 21 24 27 
CALMODULIN (ug/ml) 
Fig.2. Effect of calmodulin on Ca’+ + Mg’+-ATPase activity 
in control and TFP-pretreated plasma membranes with 
200 MM Mg’+. The plasma membrane fractions were separated, 
one-half pretreated (30 mitt, 4’C) with 100 PM TFP. Both 
fractions were assayed in the presence of 200 PM Mgs+ at 
1.1 &I free Ca ‘+ The data shows the percent stimulation .
of Cal+ + Mg’+-ATPase activity in control (0) and TFP-pre- 
treated (0) plasma membrane in response to exogenously 
added calmodulin (mean f SEM, N = 3). Ca*+ + Mgz+-ATPase 
activity in the absence of any added calmodulin was 133 f 
33 nm Pi . mg-’ . min-* and 15 * 3 nm Pi . mg-’ . min-’ for 
control and TFP pretreated membranes, respectively. 
Calmodulin (-) TFP Treatment (+) TFP Treatment 
Olglml) (nmol Pi . mg protein-’ . min-‘) 
0 147 f 29 83* 11 
2.8 146 i 28 9Oi 8 
6.0 145 i 27 91 f 10 
12.0 148 f 25 91* 9 
24.0 141 i 25 88* 7 
In each assay (N = 4-S), one-half of the plasma membrane 
fraction was pretreated (30 min, 40°C) with 100 MM TFP. 
Both control and TFP pretreated membranes were assayed 
without added Mgs* at 1 .l L.~M free CaZC (mean * SEM) 
ranging from 2.8-24 /.&ml were evaluated and as 
indicated in fig.2, Ca21-stimulated activity was 
enhanced by cahnodulin in a dose-dependent manner 
with maximal stimulation (67%) occurring at 24 hg/ml. 
Pretreatment of the plasma membrane preparation 
with TFP in an attempt o dissociate ndogenous cal- 
modulin increased the sensitivity of the Ca2+ t Mg2*- 
ATPase to exogenously added calmodulin. Under 
these conditions the maximum response of the ATPase 
to calmodulin (24 pg/ml) was increased 400% over 
the non-pretreated tissue (fig.2 upper curve). Mg’*- 
ATPase activity was not stimulated at any of the cal- 
modulin concentrations. 
To determine the Mg2+ dependency of the stimula- 
tion of the C!a2+ t Mg’+-ATPase activity by cahnodu- 
lin, similar studies were performed in the absence of 
exogenously added Mg2+ to the incubation medium. 
Under these conditions (table 2), calmodulin exerted 
no detectable ffect on the Ca2*-stimulated ATPase 
either with or without TFP pretreatment. These 
results indicate a requirement of Mg2+ for calmodulin 
enhancement of the Ca2+ t Mg2+-ATPase activity in 
this tissue preparation. 
4. DIscussion 
Our previous tudies indicated that calmodulin 
activates Ca2+ uptake by islet-cell plasma membrane 
vesicles [8]. We now demonstrate cahodulin activa- 
tion of Ca2+-stimulated ATPase activity which is 
thought o mediate this transport process. Inhibition 
of the Ca2* t Mg2+-ATPase activity by TFP, FLU, 
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and CPZ provides indirect evidence for a requirement 
of calmodulin for this enzyme activity. The relative 
degree of inhibition produced by these agents (TFP 2 
FLU > CPZ) is consistent with their effects on eryth- 
rocyte plasma membrane Ca*+ t Mg*+-ATPase activity 
and indicates that endogenous calmodulin is required 
for full enzyme activity [ 1,10,23,24]. In the eryth- 
rocyte plasma membrane, inhibition of the Ca*+ t Mg*+- 
ATPase by phenothiazines may be a reflection of 
endogenously bound calmodulin [11. This may be 
explained, in part, by the high levels of calmodulin 
present in islets [ 11,141 as well as by the apparent 
high affinity of cahnodulin for the plasma membrane 
ATPase. 
Calmodulin directly enhanced the Ca*+ t Mg*+- 
ATPase activity by 67% when 200 PM Mg*+ was present 
in the incubation medium. Since inhibition of the 
activity by phenothiazines indicated the presence of 
significant levels of endogenous calmodulin, proce- 
dures were used to more effectively remove bound 
calmodulin from this membrane preparation. In this 
approach, membranes were pretreated with TFP in 
the presence of Ca*+ to dissociate ndogenous cahno- 
dulin. TFP pretreatment reduced the Ca*+-stimulated 
ATPase activity and resulted in a 4-fold enhancement 
of the calmodulin activation of the Ca*+ t Mg*+-ATPase. 
This enhancing effect by calmodulin is most likely 
explained by replacement of calmodulin depleted by 
the pretreatment procedure. Although the effect of 
residual TFP from the pretreatment conditions is a 
consideration i this experimental design, it would be 
<l /.IM in the assay medium. 
In [ 81, calmodulin stimulation of ATP-dependent 
Ca*+ uptake in islet-cell plasma membrane vesicles 
was determined in the presence of 2 mM Mg*+. The 
presence of Mg*+ in the transport assay is thought o 
be necessary for coupling ATP hydrolysis to Ca*+ 
transport in this system. However, the failure of 
calmodulin to activate Ca*+ + Mg*+-ATPase in the 
absence of exogenously added Mg*+ as well as the 
enhancement of phenothiazine-induced inhibition 
by Mg’+ indicates arequirement for this cation for 
calmodulin activation of plasma membrane Ca*+ + 
Mg*+-ATPase. 
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